342 related articles for article (PubMed ID: 23271730)
1. Interleukin-20 promotes migration of bladder cancer cells through extracellular signal-regulated kinase (ERK)-mediated MMP-9 protein expression leading to nuclear factor (NF-κB) activation by inducing the up-regulation of p21(WAF1) protein expression.
Lee SJ; Cho SC; Lee EJ; Kim S; Lee SB; Lim JH; Choi YH; Kim WJ; Moon SK
J Biol Chem; 2013 Feb; 288(8):5539-52. PubMed ID: 23271730
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression.
Lee EJ; Lee SJ; Kim S; Cho SC; Choi YH; Kim WJ; Moon SK
Cell Signal; 2013 Oct; 25(10):2025-38. PubMed ID: 23770289
[TBL] [Abstract][Full Text] [Related]
3. p21WAF1 mediates the IL-15-induced migration and invasion of human bladder cancer 5637 cells via the ERK1/2/NF-κB/MMP-9 pathway.
Park SL; Kim WJ; Moon SK
Int Immunopharmacol; 2014 Sep; 22(1):59-65. PubMed ID: 24953855
[TBL] [Abstract][Full Text] [Related]
4. p27KIP1 is involved in ERK1/2-mediated MMP-9 expression via the activation of NF-κB binding in the IL-7-induced migration and invasion of 5637 cells.
Park SL; Lee EJ; Kim WJ; Moon SK
Int J Oncol; 2014 Apr; 44(4):1349-56. PubMed ID: 24504262
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-28A triggers wound healing migration of bladder cancer cells via NF-κB-mediated MMP-9 expression inducing the MAPK pathway.
Lee SJ; Lim JH; Choi YH; Kim WJ; Moon SK
Cell Signal; 2012 Sep; 24(9):1734-42. PubMed ID: 22560878
[TBL] [Abstract][Full Text] [Related]
6. IL-5-induced migration via ERK1/2-mediated MMP-9 expression by inducing activation of NF-κB in HT1376 cells.
Lee EJ; Park SS; Kim WJ; Moon SK
Oncol Rep; 2012 Sep; 28(3):1084-90. PubMed ID: 22710862
[TBL] [Abstract][Full Text] [Related]
7. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.
Cortez DM; Feldman MD; Mummidi S; Valente AJ; Steffensen B; Vincenti M; Barnes JL; Chandrasekar B
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3356-65. PubMed ID: 17921324
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms involved in enhancement of matrix metalloproteinase-9 expression in macrophages by interleukin-33.
Ariyoshi W; Okinaga T; Chaweewannakorn W; Akifusa S; Nisihara T
J Cell Physiol; 2017 Dec; 232(12):3481-3495. PubMed ID: 28105703
[TBL] [Abstract][Full Text] [Related]
9. 12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCalpha/ERK/NF-kappaB-dependent MMP-9 expression.
Lin CW; Shen SC; Chien CC; Yang LY; Shia LT; Chen YC
J Cell Physiol; 2010 Nov; 225(2):472-81. PubMed ID: 20458747
[TBL] [Abstract][Full Text] [Related]
10. EPO gene expression induces the proliferation, migration and invasion of bladder cancer cells through the p21WAF1‑mediated ERK1/2/NF-κB/MMP-9 pathway.
Park SL; Won SY; Song JH; Kim WJ; Moon SK
Oncol Rep; 2014 Nov; 32(5):2207-14. PubMed ID: 25175278
[TBL] [Abstract][Full Text] [Related]
11. IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression.
Lin CC; Kuo CT; Cheng CY; Wu CY; Lee CW; Hsieh HL; Lee IT; Yang CM
Cell Signal; 2009 Nov; 21(11):1652-62. PubMed ID: 19616091
[TBL] [Abstract][Full Text] [Related]
12. IL-1β promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-κB- and AP-1-dependent pathways.
Tseng HC; Lee IT; Lin CC; Chi PL; Cheng SE; Shih RH; Hsiao LD; Yang CM
PLoS One; 2013; 8(3):e57955. PubMed ID: 23505448
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
14. Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: the role of MAP kinase signaling pathways.
Lee SJ; Park SS; Cho YH; Park K; Kim EJ; Jung KH; Kim SK; Kim WJ; Moon SK
Oncol Rep; 2008 Apr; 19(4):1007-13. PubMed ID: 18357389
[TBL] [Abstract][Full Text] [Related]
15. Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.
Lee SJ; Lee EJ; Kim SK; Jeong P; Cho YH; Yun SJ; Kim S; Kim GY; Choi YH; Cha EJ; Kim WJ; Moon SK
PLoS One; 2012; 7(9):e40267. PubMed ID: 22962576
[TBL] [Abstract][Full Text] [Related]
16. Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways.
Eberhardt W; Huwiler A; Beck KF; Walpen S; Pfeilschifter J
J Immunol; 2000 Nov; 165(10):5788-97. PubMed ID: 11067938
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH
J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568
[TBL] [Abstract][Full Text] [Related]
18. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
20. Tianeptine sodium salt suppresses TNF-α-induced expression of matrix metalloproteinase-9 in human carcinoma cells via suppression of the PI3K/Akt-mediated NF-κB pathway.
Jayasooriya RG; Dilshara MG; Choi YH; Moon SK; Kim WJ; Kim GY
Environ Toxicol Pharmacol; 2014 Sep; 38(2):502-9. PubMed ID: 25168152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
